Stay updated on KZR-616 in SLE: Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in SLE: Clinical Trial page.

Latest updates to the KZR-616 in SLE: Clinical Trial page
- Check7 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information about the Phase 1b/2 study of zetomipzomib and the introduction of new references to KZR-616 and Lupus Nephritis.SummaryDifference25%
- Check14 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check72 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check79 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to KZR-616 in SLE: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in SLE: Clinical Trial page.